[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sanofi (SAN.FP)

Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanofi 46, Avenue de la Great Army Paris 75017 FRA

P: +33 153774000

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Key Statistics

Overview:

Market Capitalization, $K 93,297,146
Shares Outstanding, K 1,197,925
% of Institutional Shareholders 41.81%

Financials:

Annual Sales, $ 46,716 M
Annual Net Income, $ 7,813 M
Last Quarter Sales, $ 11,244 M
Last Quarter Net Income, $ 1,614 M

Growth:

1-Year Return -10.90%
3-Year Return -18.29%
5-Year Return -12.32%
5-Year Revenue Growth 4.57%
5-Year Earnings Growth -8.18%
5-Year Dividend Growth 4.47%

Per-Share Information:

Most Recent Earnings 1.34 on 04/23/26
Next Earnings Date N/A
Earnings Per Share ttm 6.19
EPS Growth vs. Prev Year 19.24%
Annual Dividend & Yield (Paid) 3.92 (5.29%)
Annual Dividend & Yield (Fwd) 4.12 (5.29%)
Most Recent Dividend 4.120 on 05/05/26
Next Ex-Dividends Date 05/05/26
Dividend Payable Date 05/07/26
Dividend Payout Ratio 98.99%

SAN.FP Ratios

Ratio
Price/Earnings ttm 19.68
Price/Earnings forward 9.01
Price/Earnings to Growth 3.92
Return-on-Equity % 10.29%
Return-on-Assets % 5.81%
Profit Margin % 16.72%
Debt/Equity 0.22
Price/Sales 2.00
Price/Cash Flow 9.14
Price/Book 1.28
Book Value/Share 60.83
Interest Coverage 10.86
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.